Abstract
Fibro-calcific aortic valve disease (FCAVD) is a pathological condition marked by overt fibrous and calcific extracellular matrix (ECM) accumulation that leads to valvular dysfunction and left ventricular outflow obstruction. Costly valve implantation is the only approved therapy. Multiple pharmacological interventions are under clinical investigation, however, none has proven clinically beneficial. This failure of translational approaches indicates incomplete understanding of the underlying pathomechanisms and may result from a limited toolbox of scientific methods to assess the cornerstones of FCAVD: lipid deposition, fibrous and calcific ECM accumulation. In this study, we evaluated magic-angle spinning (MAS) nuclear magnetic resonance (NMR) spectroscopy to both, qualitatively and quantitatively assess these key elements of FCAVD pathogenesis. NMR spectra showed collagen, elastin, triacylglycerols, and phospholipids in human control and FCAVD tissue samples (n = 5). Calcification, measured by the hydroxyapatite content, was detectable in FCAVD tissues and in valve interstitial cells under procalcifying media conditions. Hydroxyapatite was significantly higher in FCAVD tissues than in controls (p < 0.05) as measured by 31P MAS NMR. The relative collagen content was lower in FCAVD tissues vs. controls (p < 0.05). Overall, we demonstrate the versatility of NMR spectroscopy as a diagnostic tool in preclinical FCAVD assessment.
Subject terms: Biochemistry, Biophysics, Cell biology, Cardiology
Introduction
Fibro-calcific aortic valve disease (FCAVD) has a high prevalence especially in the aging population in the western world1. Lipid and phospholipid deposition, immune cell infiltration and inflammation, and myofibroblastic as well as osteogenic differentiation of resident valve interstitial cells (VICs) are the underlying pathomechanisms2–4. Myofibroblastic VICs actively trigger extracellular matrix (ECM) remodelling with collagen accumulation, valvular thickening and tissue calcification5. Proteoglycan degeneration and elastic fibre fragmentation further contribute to the alterations in the valvular architecture6,7. These structural changes in the connective tissue cause major hemodynamic impairment, culminating in aortic valve stenosis (AS) that associates with heart failure and substantially increases mortality8,9. Costly aortic valve (AV) implantation is available, however, limited valve durability, procedural risk and unsuitable patient characteristics are important factors that limit the clinical application10. Although progress in the mechanistic understanding of the FCAVD pathogenesis has been made, a pharmacological treatment is missing11. In recent years, preclinical in vivo and in vitro models implicated various promoting factors and molecular pathways in FCAVD12.
Elevated phosphate concentrations in the blood serum are associated with increased valvular calcification, indicating the important role of phosphate in FCAVD13,14. Therefore, in this study, a procalcifying medium (PM), containing inorganic phosphate, was used to induce passage independent calcification in VIC cultures15. However, it is not completely clear whether this in vitro modelling mirrors the complex, long-lasting in vivo FCAVD pathomechanisms. In addition, established analytical tools only depict individual molecular components like collagen, elastin, and lipids, or indicate calcification. Thus, a multitude of analytic methods is necessary for a comprehensive assessment of a single FCAVD progression stage.
Solid-state nuclear magnetic resonance (NMR) spectroscopy under magic-angle spinning (MAS) conditions acquires spectra from solid materials by direct excitation or cross polarization (CP) and identifies mobile or rigid molecules of a sample, respectively16. 13C MAS NMR allows the analysis of ECM organic compounds such as collagen, elastin, phospholipids and triglycerides17–20, while 31P NMR assesses calcification. Thus, NMR spectroscopy may represent a versatile tool to investigate major FCAVD pathomechanistic characteristics in a native specimen at once. Hence, this study focusses on the analysis of the relevant major organic and inorganic components in FCAVD tissues as well as in in vitro models using 13C and 31P MAS NMR. ECM quantification using conventional histochemical methods is challenging because of its restriction to exemplary two-dimensional tissue sections. Thus, special attention was payed to the ECM quantification in vivo and in vitro using NMR spectra.
Results
13C Solid-state NMR of organic aortic valve components and organic cell culture material
To characterize the ECM composition in healthy control tissue (CT) and end-stage FCAVD tissues, solid-state 13C NMR spectroscopy was performed (Fig. 1). 13C CP MAS NMR spectra are sensitive to the immobile components of the ECM and predominantly identified collagen (Fig. 1, upper panel).
In the directly excited 13C NMR spectra, the signals of phospholipids (PL) and triacylglycerols (TAG) were dominating, representing a superposition of both compounds. As only the chemical environment influences the chemical shift, the lipid chains of the PLs and TAGs exhibit the same fingerprint in the aliphatic range between 10 and 40 ppm as well as for the unsaturated hydrocarbon (130 ppm) and glycerol signals (see Fig. 1c, gray). However, different headgroups of PLs can be distinguished depending on their chemical shift, e.g., phosphatidylethanolamine (PE, green), phosphatidylglycerol (PG, purple) and phosphatidylcholine (PC, red) in Fig. 1c. Only a minor peak of the characteristic methyl groups (Cγ) of the PC head group was identified around 55 ppm (Fig. 1). Hence, PCs did not represent the majority of the detected PLs and TAGs. Furthermore, an overall trend of higher PL and TAG content in the CT was observed compared to FCAVD tissue as indicated by higher signal intensities in the aliphatic region, of the double bond signal (130 ppm) as well as of the CO signal in the CT spectra.
Employing the hydroxyproline Cγ (Hyp Cγ) intensity and the internal standard polyoxymethylene (POM) as well as the sample weight in the CP spectra, the relative collagen amount per mg sample was determined. It was decreased in FCAVD tissues compared to CT (Fig. 2; CT: 0.55 ± 0.03 AU, FCAVD: 0.37 ± 0.04 AU; p < 0.05, n = 5).
In parallel, VIC in vitro cultures were analyzed by 13C MAS NMR. Directly excited NMR spectra revealed low signal to noise ratio (SNR). The 13C CP NMR spectra showed no specific signals for collagen (Suppl. Fig. 1), which is in contrast to FCAVD tissues. Two PM-treated VIC cultures showed a prominent signal around 30 ppm (green and red line, Suppl. Fig. 1). This signal is assigned to chemically equivalent CH2 groups of fatty acids21. However, the broad line shape and the good CP sensitivity indicated restricted motion of the fatty acids.
All other samples had lower signal intensities and a low SNR in the 13C NMR spectra and were not further analyzed as optimization of the CP step, which crucially influences the observed peak intensity, is not possible without sufficient signal intensity.
31P solid-state NMR of inorganic components in aortic valves and cell culture
31P MAS NMR was used to identify and characterize calcification in FCAVD tissues and PM-treated VICs. Direct excitation detects all phosphorous species in the sample, whereas CP NMR spectra detect only signals from rigid phosphorous moieties in close proximity to hydrogens. As for 13C, the chemical shift of 31P is highly sensitive to the chemical environment. Taken together, this allows to assess the degree of calcification of the specimen, as hydroxyapatite (HAP) can be identified using both spectra and quantified in the directly excited spectrum (see Fig. 3c for reference). In FCAVD tissues, distinct 31P NMR spectra representing HAP were detected in all samples (by direct excitation and CP, Fig. 3b).
A minor phosphorous signal, which was, for most specimen, slightly shifted compared to the HAP signal in FCAVD tissue (dashed line) and therefore does not represent HAP, was observed in directly excited NMR spectra of CT (Fig. 3a, lower panel, 30 times magnified). Furthermore, none of these signals were cross polarizable, indicating the lack of nearby protons. Thus, no HAP was detected in CP NMR spectra (Fig. 3) for CT tissue. NMR spectral integral of the directly excited spectra was used to calculate and compare the amount of mineralization between FCAVD and CT (Fig. 4, CT: 16 ± 6 AU, FCAVD: 788 ± 126 AU; p < 0.05). The uncertainties due to imperfections of pulse calibration and integration were determined to be below 5% (see “Materials and methods”).
PM treatment reproducibly induced calcific mineral deposition as quantified by Alizarin Red in the VIC in vitro model (Fig. 5a, p < 0.05). However, 31P MAS NMR provided a weak signal intensity in PM-treated VICs, except for two specimen (green and red colour, Suppl. Fig. 2) which also had a calcified fatty acid signal in the 13C CP NMR spectra (see above). Furthermore, one control medium (CM)-treated sample showed a low HAP signal. The quantification of the phosphorous amount in all experimental groups was comparable (Fig. 5b).
Discussion
NMR spectroscopy has been used for the analysis of a multitude of biological tissues17–20,22 especially in vascular calcification, which shares features with FCAVD23,24. In this study, we demonstrate, for the first time, that NMR spectroscopy is eminently suitable for the detection and quantification of major components of the valvular ECM in vivo in non-diseased and diseased aortic valves as well as in VIC in vitro cultures. In particular, this NMR-based analysis revealed and quantified:
Triglycerides, phospholipids, collagen and elastin in valvular CT and FCAVD tissues.
Increased HAP content and lower collagen content in FCAVD tissues compared to controls.
Fatty acids undergoing restricted motion on the NMR timescale in PM-treated VIC cultures.
Mineralized and non-mineralized ECM components in aortic valve tissue are frequently analyzed by histochemistry, immunohistochemistry, electron microscopy, infrared spectroscopy, and x-ray-based techniques25–28. These methods detect particular ECM components, but are limited in their applicability to screen and quantify multiple ECM elements in parallel.
NMR spectroscopy has the distinct advantage that biological tissue can be investigated without the need for fixation, staining or other treatments. Organic and inorganic components are analyzed within the same sample by 13C and 31P MAS NMR spectroscopy at once17 allowing for a qualitative and quantitative characterization of major ECM components. Accordingly, lipids and phospholipids, collagen, elastin and HAP, key players in FCAVD pathophysiology17,29, were identified using NMR. Collagen was inversely correlated with HAP content. While calcification was increased in FCAVD, the collagen content per mg wet sample weight was decreased compared to CT. Although these results are consistent with prior data suggesting collagen degradation as well as calcific mineral accumulation in FCAVD30,31, the total collagen per leaflet might still be increased in FCAVD relative to CT32. Regarding the role of lipids in FCAVD pathophysiology, accumulating evidence suggests that oxidized phospholipids carried by lipoprotein a, may initiate a complex inflammatory process leading to aortic valve calcification33,34. Interestingly, we observed that the relative content of lipids, especially TAGs, was slightly reduced in FCAVD compared to healthy CT.
NMR spectroscopy on PM-treated VICs in vitro proved that HAP formation is evident as well as in in vivo calcification25. Thus, PM treatment might represent a sufficient calcification model to reproduce valvular ECM mineralization in vitro. Nevertheless, in this study two of five samples showed HAP formation as detected by 31P MAS NMR, whereas Alizarin red staining detected calcification in all samples. Natural variability in human primary cell cultures, patient-specific variability and the staining of all calcium containing mineral material by Alizarin red may have caused this discrepancy13.
Surprisingly, the NMR method did not detect glycosaminoglycans (GAGs), which are considered to represent a major component of the spongiosa layer25, suggesting that GAG concentration is at least ten fold below the readily detectable lipids/TAGs. While the GAG content may be below the detection limit in CT, the missing signal is surprising for FCAVD tissue, where excess production of GAGs and proteoglycans has been described29,35.
Co-detection of collagen and elastin, both important ECM components of the AV, by NMR, is rather difficult, since it is known that NMR spectra of elastin are strongly influenced by the water content36. Due to the water uptake of isolated elastin, spectral intensity increases at lower humidity36. Hence, the detection of elastin was more straightforward in the FCAVD tissue due to its lower water content secondary to the higher calcific mineral content. Regarding the quantification of collagen, the hydroxyproline Cγ (Hyp Cγ) resonance around 71 ppm is used, as hydroxyproline content of collagen is roughly 13%. However, elastin also contains 1–2% of hydroxyproline37,38 and is about 3.4 times less abundant than collagen in the AV32. Hence, a maximum of 4.3% of the detected hydroxyproline may originate from elastin instead of collagen and this may result in a slight overestimation of the collagen content. However, as this is within the margins of error for quantification using NMR and holds true for both, control and FCAVD tissues, we used the Hyp Cγ signal for the semi-quantitative assessment of the collagen content.
In this study, an inconsistent detection of HAP by NMR compared to reproducible detection by Alizarin red was observed. The extraction method used for NMR detection may not be sufficient to extract the firmly bound HAP from the cell culture dish. Hence, harsher extraction methods may be used to optimize the extraction yield of significantly mineralized VIC matrices. Harsher extraction, of more firmly bound matrix generated by the cells treated with PM, resulted in small remnants of plastic, not visible by eye, produced during the scratching procedure. These plastic impurities, from the cell culture dish, produced high intensity NMR peaks, which hindered adequate interpretation of NMR signals in the 13C CP spectra and the calculation of relative amounts, as the plastic impurities also contribute to the sample weight.
In summary, NMR analyses require a high amount of sample material, which is suitable for tissue biopsy analyses, but demands large cell cultures with adapted extraction methods. Applying additional 13C labelling might enhance sensitivity of NMR-based cell culture analyzes. However, NMR spectroscopy represents a suitable tool to monitor ECM remodelling characteristics in FCAVD progression in diseased tissue and in in vitro calcification models.
Materials and methods
Human tissue
FCAVD tissues were obtained from patients undergoing aortic valve replacement for severe AS. The study was approved by the local Ethical Committee (Medical Faculty, University Leipzig, registration number 128/19-ek) and all patients gave written informed consent in accordance with the Declaration of Helsinki. All samples showed macroscopic calcification as a sign of progressed FCAVD. Five non-diseased tricuspid aortic valves were removed from body donors (kindly provided by the Institute of Anatomy of the University of Leipzig (CT, IRB 129/21-ek)).
VIC isolation and cultivation
FCAVD tissue obtained from aortic valve replacement was washed immediately in phosphate-buffered saline (PBS) and was scratched with a razor blade to remove endothelial cells. Leaflets were cut into small fragments of about 1 mm3, transferred into 15 ml serum-free Dulbecco's Modified Eagle Medium (DMEM; Gibco) containing 1 mg/ml collagenase (Clostridium histolyticum; Sigma-Aldrich) and incubated for 60 min at 37 °C with repeated shaking. Subsequently, tissue fragments were washed with DMEM and the supernatant with remaining endothelial cells was discarded. The tissue was immersed in collagenase solution and digestion was maintained for another 180 min, before the mixture was mixed, filtered through a 40 µm cell strainer and centrifuged at 2000 rpm for 7 min. The cells were cultivated in DMEM containing 10% fetal bovine serum (FBS; PAN Biotech) and 1% penicillin/streptomycin (P/S; Sigma Aldrich) up to a confluency of 90%. All experiments were performed in passages 3–4.
VICs were cultivated up to a 100% confluency and then assigned to: (i) cultivation in control medium (DMEM, + 5% FBS and + 1% P/S) or (ii) cultivation in PM (CM + 50 µg/ml l-ascorbic acid (Sigma-Aldrich) + 2 mM sodium phosphate (NaH2PO4; Sigma-Aldrich)). The medium was exchanged every 2–3 days. After 21 days, cell samples were washed twice with distilled water and harvested for further analysis.
Alizarin red staining and quantification
Alizarin red staining was used to visualize and quantify in vitro calcification. The cells were washed with 1 × PBS, fixed with 10% formaldehyde for 15 min, washed twice with distilled water, incubated with 2% Alizarin Red solution (LifeLine Cell Technology) for 20 min at room temperature and finally washed three times with distilled water to remove excess stain. Then 100 mM hexadecylpyridinium chloride (Sigma-Aldrich) was added and incubated for three hours at room temperature before absorbance was measured at 540 nm (Infinite 200Pro, Tecan i-control) to quantify the Alizarin red staining.
Solid-state NMR spectroscopy
13C and 31P MAS NMR measurements were performed on a 700 MHz Bruker Neo NMR spectrometer equipped with 3.2 mm E-free and 3.2 mm HFX probes. Valve tissue was homogenized by crushing in liquid nitrogen as previously described25. Samples were transferred into a 3.2 mm rotor including a small piece of polyoxymethylene (POM) serving as internal standard.
13C MAS NMR experiments were performed at 4 °C and an MAS frequency of 10 kHz. For 13C NMR spectra with direct excitation 13,312 scans were recorded using an Hahn echo sequence with a 4 µs long 90° excitation pulse for 13C, low power proton decoupling (Spinal64) during acquisition with a field strength of 6.25 kHz and a recycle delay of 5 s. For CP (excitation of 13C nuclei via dipolar couplings from spatially close protons) 13C NMR spectra, 8192 scans with a 90° 1H excitation pulse of 4 µs length, a CP contact time of 0.7 ms with a 1H CP spin lock field of 51.5 kHz and a recycle delay of 2.3 s were collected under Spinal64 decoupling of ωH/2π = 62.5 kHz during detection. Spectra were processed using Topspin 4.0.9 with an exponential line broadening of 50 Hz and 200 Hz for directly excited and CP NMR spectra, respectively. For figures, spectra were scaled using the sample weight without the internal standard to yield an intensity per mg wet sample, to allow visual inspection. For semi-quantitative assessment of the collagen content, the intensity of the Hyp Cγ resonance in the CP NMR spectrum as well as intensity of the POM was used as described before39.
31P NMR spectra were acquired at 4 °C and 20 kHz using a 4 µs 90° excitation pulse for 1H or 31P. For directly excited NMR spectra, 40 scans with Hahn echo excitation and a recycle delay of 400 s were acquired with a 1H decoupling field strength of 28 kHz. 31P CPMAS spectra had a recycle delay of 4 s, a contact time of 0.7 ms, a 1H spin lock field of 62.5 kHz and a decoupling field of 28 kHz during acquisition of the 512 scans. NMR spectra were processed with an exponential line broadening of 200 Hz and scaled as described for the 13C NMR spectra. Integration of the directly excited spectra was performed for quantification as the receiver gain and number of scans were kept constant during measurements. As quality control, a reference specimen consisting of HAP nanoparticles was measured weekly to ensure stable sensitivity of the spectrometer. These four measurements of the control substance yielded signal integrals in the directly excited spectra with a maximal deviation of 3.9% of the mean value, allowing quantification without internal standard.
Statistical analyses
Data was analyzed using two-sided t-test (GraphPad, PRISM, V8). Statistical analysis of the collagen and hydroxyapatite content measured by NMR was performed using a two tailed Mann–Whitney U test. All p-values < 0.05 were considered statistically significant.
Supplementary Information
Abbreviations
- AS
Aortic valve stenosis
- CM
Control media
- CP
Cross polarization
- CT
Control tissue
- ECM
Extracellular matrix
- FCAVD
Fibro-calcific aortic valve disease
- GAG
Glycosaminoglycans
- HAP
Hydroxyapatite
- Hyp Cγ
Hydroxyproline Cγ
- MAS
Magic angle spinning
- NMR
Nuclear magnetic resonance
- PC
Phosphatidylcholine
- PE
Phosphatidylethanolamine
- PG
Phosphatidylglycerol
- PL
Phospholipids
- POM
Polyoxymethylene
- PM
Procalcifying media
- SNR
Signal-to-noise ratio
- TAG
Triacylglycerols
- VIC
Valve interstitial cell
Author contributions
F.S. and D.H. designed, evaluated and discussed the experiments. L.F. and A.P. performed the experiments. J.B., P.B. and H.T. assisted in the acquisition of the data. All co-authors interpreted the data. L.F., A.P. and F.S. wrote the main manuscript text with contributions from all co-authors. All authors reviewed the manuscript.
Funding
Open Access funding enabled and organized by Projekt DEAL. Funded by the Open Access Publishing Fund of Leipzig University supported by the German Research Foundation within the program Open Access Publication Funding.
Data availability
The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Lukas Feistner and Anja Penk.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-023-46143-7.
References
- 1.Yadgir S, et al. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990–2017. Circulation. 2020;141:1670–1680. doi: 10.1161/CIRCULATIONAHA.119.043391. [DOI] [PubMed] [Google Scholar]
- 2.Kaden JJ, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc. Pathol. 2005;14:80–87. doi: 10.1016/j.carpath.2005.01.002. [DOI] [PubMed] [Google Scholar]
- 3.Rajamannan NM, et al. Calcific aortic valve disease: Not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation. 2011;124:1783–1791. doi: 10.1161/CIRCULATIONAHA.110.006767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90:844–853. doi: 10.1161/01.cir.90.2.844. [DOI] [PubMed] [Google Scholar]
- 5.Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am. J. Pathol. 2007;171:1407–1418. doi: 10.2353/ajpath.2007.070251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.New SE, Aikawa E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ. Res. 2011;108:1381–1391. doi: 10.1161/CIRCRESAHA.110.234146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gomez-Stallons MV, et al. Calcification and extracellular matrix dysregulation in human postmortem and surgical aortic valves. Heart. 2019;105:1616–1621. doi: 10.1136/heartjnl-2019-314879. [DOI] [PubMed] [Google Scholar]
- 8.Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N. Engl. J. Med. 1999;341:142–147. doi: 10.1056/NEJM199907153410302. [DOI] [PubMed] [Google Scholar]
- 9.Pasipoularides A. Calcific aortic valve disease: Part 1—Molecular pathogenetic aspects, hemodynamics, and adaptive feedbacks. J. Cardiovasc. Transl. Res. 2016;9:102–118. doi: 10.1007/s12265-016-9679-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Daubert MA, et al. Long-term valve performance of TAVR and SAVR: A report from the PARTNER I trial. JACC Cardiovasc. Imaging. 2016 doi: 10.1016/j.jcmg.2016.11.004. [DOI] [PubMed] [Google Scholar]
- 11.Hutcheson JD, Aikawa E, Merryman WD. Potential drug targets for calcific aortic valve disease. Nat. Rev. Cardiol. 2014;11:218–231. doi: 10.1038/nrcardio.2014.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Rutkovskiy A, et al. Valve interstitial cells: The key to understanding the pathophysiology of heart valve calcification. J. Am. Heart Assoc. 2017 doi: 10.1161/JAHA.117.006339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Böttner J, et al. High resolution monitoring of valvular interstitial cell driven pathomechanisms in procalcific environment using label-free impedance spectroscopy. Front. Cardiovasc. Med. 2023 doi: 10.3389/fcvm.2023.1155371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Linefsky JP, et al. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: The cardiovascular health study. J. Am. Coll. Cardiol. 2011;58:291–297. doi: 10.1016/j.jacc.2010.11.073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Goto S, et al. Standardization of human calcific aortic valve disease in vitro modeling reveals passage-dependent calcification. Front. Cardiovasc. Med. 2019;6:49. doi: 10.3389/fcvm.2019.00049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Huster D, Schiller J, Arnold K. Comparison of collagen dynamics in articular cartilage and isolated fibrils by solid-state NMR spectroscopy. Magn. Reson. Med. 2002;48:624–632. doi: 10.1002/mrm.10272. [DOI] [PubMed] [Google Scholar]
- 17.Murgoci A, Duer M. Molecular conformations and dynamics in the extracellular matrix of mammalian structural tissues: Solid-state NMR spectroscopy approaches. Matrix Biol. Plus. 2021;12:100086. doi: 10.1016/j.mbplus.2021.100086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Silverstein MC, et al. 13C, 2h NMR studies of structural and dynamical modifications of glucose-exposed porcine aortic elastin. Biophys. J. 2015;108:1758–1772. doi: 10.1016/j.bpj.2015.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Schiller J, Arnold K. Application of high resolution 31P NMR spectroscopy to the characterization of the phospholipid composition of tissues and body fluids—A methodological review. Med. Sci. Monit. 2002;8:MT205-222. [PubMed] [Google Scholar]
- 20.Schulz J, et al. Quantitative monitoring of extracellular matrix production in bone implants by 13C and 31P solid-state nuclear magnetic resonance spectroscopy. Calcif. Tissue Int. 2007;80:275–285. doi: 10.1007/s00223-007-9007-3. [DOI] [PubMed] [Google Scholar]
- 21.Reid DG, et al. Lipids in biocalcification: Contrasts and similarities between intimal and medial vascular calcification and bone by NMR. J. Lipid Res. 2012;53:1569–1575. doi: 10.1194/jlr.M026088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Marchandise X, Belgrand P, Legrand AP. Solid-state 31P NMR spectroscopy of bone and bone substitutes. Magn. Reson. Med. 1992;28:1–8. doi: 10.1002/mrm.1910280102. [DOI] [PubMed] [Google Scholar]
- 23.Guo W, Morrisett JD, DeBakey ME, Lawrie GM, Hamilton JA. Quantification in situ of crystalline cholesterol and calcium phosphate hydroxyapatite in human atherosclerotic plaques by solid-state magic angle spinning NMR. Arterioscler. Thromb. Vasc. Biol. 2000;20:1630–1636. doi: 10.1161/01.atv.20.6.1630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Guo W, Morrisett JD, Lawrie GM, DeBakey ME, Hamilton JA. Identification of different lipid phases and calcium phosphate deposits in human carotid artery plaques by MAS NMR spectroscopy. Magn. Reson. Med. 1998;39:184–189. doi: 10.1002/mrm.1910390204. [DOI] [PubMed] [Google Scholar]
- 25.Schlotter F, et al. Spatiotemporal multi-omics mapping generates a molecular atlas of the aortic valve and reveals networks driving disease. Circulation. 2018;138:377–393. doi: 10.1161/CIRCULATIONAHA.117.032291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Yabusaki K, et al. Quantification of calcified particles in human valve tissue reveals asymmetry of calcific aortic valve disease development. Front. Cardiovasc. Med. 2016;3:44. doi: 10.3389/fcvm.2016.00044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Perrotta I, Davoli M. Collagen mineralization in human aortic valve stenosis: A field emission scanning electron microscopy and energy dispersive spectroscopy analysis. Ultrastruct. Pathol. 2014;38:281–284. doi: 10.3109/01913123.2014.901468. [DOI] [PubMed] [Google Scholar]
- 28.Orzechowska S, Wrobel A, Goncerz G, Podolec P, Rokita E. Physicochemical and micro-tomographic characterization of inorganic deposits associated with aortic stenosis. J. Heart Valve Dis. 2014;23:40–47. [PubMed] [Google Scholar]
- 29.Lindman BR, et al. Calcific aortic stenosis. Nat. Rev. Dis. Primers. 2016;2:16006. doi: 10.1038/nrdp.2016.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Rodriguez KJ, Masters KS. Regulation of valvular interstitial cell calcification by components of the extracellular matrix. J. Biomed. Mater. Res. A. 2009;90:1043–1053. doi: 10.1002/jbm.a.32187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Eriksen HA, et al. Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis. Atherosclerosis. 2006;189:91–98. doi: 10.1016/j.atherosclerosis.2005.11.034. [DOI] [PubMed] [Google Scholar]
- 32.Bashey RI, Torii S, Angrist A. Age-related collagen and elastin content of human heart valves. J. Gerontol. 1967;22:203–208. doi: 10.1093/geronj/22.2.203. [DOI] [PubMed] [Google Scholar]
- 33.Mathieu P, Boulanger MC. Autotaxin and lipoprotein metabolism in calcific aortic valve disease. Front. Cardiovasc. Med. 2019;6:18. doi: 10.3389/fcvm.2019.00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Capoulade R, et al. Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis. J. Am. Coll. Cardiol. 2015;66:1236–1246. doi: 10.1016/j.jacc.2015.07.020. [DOI] [PubMed] [Google Scholar]
- 35.Hinton RB, Jr, et al. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ. Res. 2006;98:1431–1438. doi: 10.1161/01.RES.0000224114.65109.4e. [DOI] [PubMed] [Google Scholar]
- 36.Perry A, Stypa MP, Tenn BK, Kumashiro KK. Solid-state (13)C NMR reveals effects of temperature and hydration on elastin. Biophys. J. 2002;82:1086–1095. doi: 10.1016/S0006-3495(02)75468-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Neuman RE, Logan MA. The determination of hydroxyproline. J. Biol. Chem. 1950;184:299–306. doi: 10.1016/S0021-9258(19)51149-8. [DOI] [PubMed] [Google Scholar]
- 38.Bentley JP, Hanson AN. The hydroxyproline of elastin. Biochim. Biophys. Acta. 1969;175:339–344. doi: 10.1016/0005-2795(69)90011-7. [DOI] [PubMed] [Google Scholar]
- 39.Forster Y, et al. The influence of different artificial extracellular matrix implant coatings on the regeneration of a critical size femur defect in rats. Mater. Sci. Eng. C Mater. Biol. Appl. 2020;116:111157. doi: 10.1016/j.msec.2020.111157. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.